Immediate Implant Placement With Different Materials of Customized Healing Abutment for Guiding Peri-implant Soft Tissue Healing in Posterior Teeth
Immediate Implant Placement With Different Materials of Customized Healing Abutment for Guiding Peri-implant Soft Tissue Healing in Posterior Teeth: A Randomized Controlled Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
This randomized clinical trial evaluates the effect of customized PEEK healing abutment versus composite healing abutment regarding Clinical evaluate
- Gingival margin height
- Gingival contour width
- Gingival volume in BL & MD aspects on guiding the peri- implant soft tissue emergency profile in posterior teeth after immediate implant placement
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Marwa Helal
- Phone Number: 01125141408
- Email: marwa.helal@dentistry.cu.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 02
- Marwa Helal
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Inclusion Criteria of participants:
- Periodontally and systemic healthy patients
- Patients aged > 18 years
- Non- restored teeth for many reasons (i.e. endodontic failure, unworthy for treatment in deep caries/non-caries lesion and root fracture), locate in the posterior area in the maxillary or mandibular arch indicate for customized implant with no need for additional bone and soft tissue augmentation procedures.
- An adequate vertical bone for immediate implant placement.
- Implants will be positioned with adequate primary stability so that transmucosal healing can be accomplished.
- No taken medications known to interfere healing or periodontal tissue health or bone metabolism.
- No previous periodontal surgery at involved sites.
- Good oral hygiene and good compliance with the plaque control instructions following initial therapy.
Exclusion criteria:
- Patients with active periodontal diseases (bleeding on probing- probing depth > 4 mm) or those under orthodontic treatment.
- Poor oral hygiene (full mouth plaque score > 25% and full mouth bleeding score > 25%)
- Smoking habits (> 10 cigarettes/day)
- Severe acute or chronic periodontitis
- Severe bruxism habits
- History of oral/IV bisphosphonates taking
- Remote or recent radiation therapy in the oro-maxillo-facial area or recent chemotherapy.
- Xerostomia
- Pregnant and lactating mothers
- Patients who have been received periodontal surgery in the study area during the last year.
- Clinical or radiographic signs of periapical pathology contraindicating immediate implant placement.
- Implants showing signs of peri-implant mucositis and peri-implantitis during the study period will be excluded from the following analyses.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: immediate implant placement with customized composite healing abutment
|
|
|
Experimental: immediate implant placement with customized PEEK healing abutment
|
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gingival margin height
Time Frame: Day 0 - month 12
|
Gingival margin height will be measured from the highest gingival margin point in the buccal, lingual, mesial, and distal sides perpendicular to the platform plane (buccal height; BH, palatal/lingual height; LH, mesial height; MH and distal height; DH).
|
Day 0 - month 12
|
|
Gingival contour width
Time Frame: Day 0 - month 12
|
The contour width will be measured from the outer sur face on the buccal and lingual sides to the implant center on the platform plane (buccal width; BW and palatal/lingual width; LW).
|
Day 0 - month 12
|
|
Gingival volume in BL & MD aspects
Time Frame: Day 0 - month 12
|
Gingival volume will be measured on the gingiva above the platform plane for total gingival volume and separated with a mid-mesiodistal plane through the implant center for buccal and lingual gingival volume (total buccolingual volume; BLV, buccal volume; BV and lingual volume; LV).
|
Day 0 - month 12
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Functional Implant Prosthodontics Score
Time Frame: Day 0 - month 12
|
The Functional Implant Prosthodontics Score will be measured through five variables in order to limit bias: (1) interproximal contact and papillae, (2) occlusion static and dynamic, (3) design color and contour, (4) mucosa quality and quantity, and (5) bone x-ray.
A scoring scheme of 0-1-2 resulting in a maximum score of ten (5X2) per implant reconstruction.
|
Day 0 - month 12
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numerical rating scale
Time Frame: Day 0 - 2 hours- 24 hours
|
is a psychometric response to pain scale which will be used in questionnaires through asking the patients about the occurrence of discomfort and postoperative pain Will be evaluated by questionnaire to assess perceived pain following crown insertion
|
Day 0 - 2 hours- 24 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 591024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.